Renouveau Medspa’s Unique Story: Science-Driven, Ethical Aesthetic Care

Renouveau Medspa was founded in 2021 by Dr. Yalda Naeini, with a clear vision: to bridge medical science and aesthetic artistry. With a background in cellular biology and diagnostic pathology, Dr. Naeini recognized a gap in aesthetic medicine, treatments that looked good short-term but didn’t truly support skin health long-term. The practice began with the launch of the Renouveau skincare line, designed to work synergistically with collagen-stimulating lasers and devices to enhance results from the inside out.

Our mission is to help patients look refreshed, confident, and natural, never overdone, while prioritizing long-term skin health. We believe aesthetic medicine should enhance how you feel, not change who you are. Education, prevention, and scientifically grounded treatments are at the core of everything we do.

We practice science-driven, personalized aesthetics. Every face and body is unique, and treatments should reflect that. We focus on cellular rejuvenation, collagen restoration, and skin integrity, rather than quick fixes or trends.

Our advanced collagen-stimulating laser and device protocols, paired with medical-grade skincare formulated by Dr. Naeini, set us apart. Treatments are strategically layered to stimulate the skin at a cellular level, maximizing results while maintaining a natural appearance.

We take the time to listen, educate, and customize. Every patient receives a comprehensive consultation focused on their goals, lifestyle, and skin biology. We prioritize transparency, realistic expectations, and long-term planning rather than one-size-fits-all treatments.

No two days are the same. Each day blends patient care, education, innovation, and collaboration. Our team thrives in a dynamic environment where science, aesthetics, and patient relationships intersect.

We want every patient to know that they are in expert medical hands. Every recommendation is grounded in science, safety, and integrity, with their best interest always at the center.

Our proudest moments are when patients tell us they feel confident, refreshed, and truly themselves again, often hearing they look “well-rested” rather than “treated.” Long-term patient trust and loyalty are our greatest achievements.

Scientific. Personalized. Ethical.

Trust is built through honesty, education, and consistency. We explain every treatment, answer questions thoroughly, and never pressure patients. Our goal is to create a space where patients feel heard, respected, and confident in their care.

Like many patients, Dr. Naeini has personally witnessed how skin aging and confidence are deeply connected. This understanding drives a compassionate, thoughtful approach focused on empowerment, not perfection.

We actively participate in community education initiatives, emphasizing skin health, prevention, and safe aesthetic practices. Giving patients accurate information has been one of the most impactful ways we serve beyond our doors.

A fascination with human biology and disease at the cellular level inspired Dr. Naeini to pursue medicine. Today, she is motivated by helping patients feel confident while applying rigorous scientific principles to aesthetic medicine.

Dr. Naeini maintains active involvement in professional medical and aesthetic organizations to stay current with the latest advancements, technologies, and safety standards.

– Who’s Who by Marquise

The decision to become a physician developed early around 2002, driven by a passion for science, medicine, and problem-solving.

A deep curiosity about how the body functions, and how science can be applied to improve quality of life, ultimately inspired her journey into medicine.

Dr. Naeini has a background in diagnostic pathology and cellular biology, contributing to a strong foundation in evidence-based medicine that informs her aesthetic practice.

● Mizuno S, Bustos MA, Hayashi Y, Abe K, Furuhashi S, Naeini Y, Xu X, Bilchik AJ, Hoon DSB. Induced collagen type-I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour-infiltrating lymphocytes. Clin Transl Med. 2024 Nov;14(11):e70067. doi: 10.1002/ctm2.70067. PMID: 39496484

● Furuhashi S, Bustos MA, Mizuno S, Ryu S, Naeini Y, Bilchik AJ, Hoon DSB. Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment. NPJ Precis Oncol. 2023 Nov 14;7(1):118. doi: 10.1038/s41698-023-00474-w.PMID: 37964075

● Strobel KM, Crane JN, Bradford KL, Naeini Y, May WA, Chang VY. Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis. Cancer Genet. 2019 Nov;239:33-35. doi: 10.1016/j.cancergen.2019.09.001. Epub 2019 Sep 4. PMID: 31520998

● Uppal A, Dehal A, Chang SC, Barrak D, Naeini Y, Jalas JR, Bilchik AJ. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. J Gastrointest Surg. 2020 Jan;24(1):28-38. doi: 10.1007/s11605-019-04403-w. Epub 2019 Oct 17. PMID: 31625020

● Garland-Kledzik M, Uppal A, Naeini YB, Stern S, Erali R, Scholer AJ, Khader AM, Santamaria-Barria JA, Cummins-Perry K, Zhou Y, Votanopoulos KI, Shen P, Levine EA, Bilchik AJ.  Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC).

● J Gastrointest Surg. 2021 Jan;25(1):233-240. doi: 10.1007/s11605-020-04886-y. Epub 2020 Dec 2. PMID: 33269456

● Naeini YB, Wu A, O’Malley DP. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population. Ann Diagn Pathol. 2016 Dec;25:7-14. doi:10.1016/j.anndiagpath.2016.07.008. Epub 2016 Aug 17.PMID: 27806850

● Yalda B. Naeini, Ramir Arcega, Nagesh Rao, Haodong Xu. Post-irradiation pericardial malignant mesothelioma with deletion P16: a case report and review of the literature. Cancer Biol Med. 2018 Feb;15(1):97-102. doi: 10.20892/j.issn.2095-3941.2017.0169.

● Lee PM, Siangchin K, Song S, Shabsovich D, Naeini Y, Tirado CA. An Adult Male Presenting with Concurrent Plasma Cell Myeloma Involving a CCND1-IGH Translocation and Chronic Myelogenous Leukemia with a Variant (9;22) Translocation. J Assoc Genet Technol. 2016;42(2):60-3. PMID: 27584682

● Azadeh Esmaeili MD, Yalda B. Naeini, Sherwin Toluie, Kimia Davoodi, Aryan Esmaeili, Samra Vazirian, Georgette Buga: An overview on biological mechanisms of ApoA-I mimetic peptide to reduce cognitive impairment induced by hyperlipidemia and Alzheimer’s disease via vascular pathway and neurodegenerative mechanism. Journal of Scientific Research in Allied Sciences. ISSN NO. 2455-5800

● Shabsovich D, Schiller G, Naeini Y, Collins R, Tirado CA. Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype. Assoc Genet Technol. 2017;43(1):20-22. PMID:28459703

● Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsneider M, Nghiemphu PL, Lai A, Liau LM, Cloughesy TF, Yong WH. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neurooncol. 2017 Apr;132(2):351-358. doi: 10.1007/s11060-017-2377-0. Epub 2017 Feb 4.PMID: 28161760

● Peggy S Sullivan, Peter Shintaku, Madhuri Wadehra, Yalda B Naeini, Neda A Moatamed. Unlike Prostate, ERG Is Not Expressed in Endometrial Lesions. Int J Clin Exp Pathol 2016;9(2):2159-2163

● Derek W. Wang, Ekaterina I. Mokhonova, Genevieve C. Kendall, Diana Becerra, Yalda B. Naeini, Melissa J. Spencer, Stanley F. Nelson, M. Carrie Miceli. Repurposing Dantrolene for Long-term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx mouse. Molecular therapy, Nucleic Acids. Volume 11, 1 June 2018, Pages 180-191

● Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Eskin A, Chowdhury R, Phillips HS, Nghiemphu PL, Behbahanian Y, Ellingson BM. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol. 2013 May;15

● Harris RJ, Cloughesy TF, Pope WB, Godinez S, Natsuaki Y, Nghiemphu PL, Meyer H, Paul D, Behbahanian Y, Lai A, Ellingson BM. Pre- and post- contrast three-dimensional double inversion- recovery MRI in human glioblastoma. J Neurooncol. 2013

● Ellingson BM, Yalda Behbahanian (acknowledgements). Probabilistic Radiographic Atlas of Glioblastoma Phenotypes. AJNR Am J Neuroradiol. 2013

● Ted Farzaneh, Carlos Tirado, Yalda Naeini, Justin Buchanan. The t(12;21) Translocation in the Context of a Complex Karyotype in Pediatric B-ALL. May 2016 DOI: 10.1016/j.cancergen.2016.05.047